Results showed no new safety signals or concerns with the use of Favipiravir, and already-known side effects like weakness, gastritis, diarrhoea, vomiting etc were found to be mild in nature. The time for fever resolution was 4 days, while the time for the clinical cure was 7 days, it added.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3kag9mF
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Glenmark concludes study on COVID drug Favipiravir
0 comments:
Post a Comment